Brunner, H. I., & Lutz, T. (2018). Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase III open-label study. Arthritis & rheumatology, 70(7), . https://doi.org/10.1002/art.40466
Chicago Style (17th ed.) CitationBrunner, Hermine I., and Thomas Lutz. "Subcutaneous Abatacept in Patients with Polyarticular-course Juvenile Idiopathic Arthritis: Results from a Phase III Open-label Study." Arthritis & Rheumatology 70, no. 7 (2018). https://doi.org/10.1002/art.40466.
MLA (9th ed.) CitationBrunner, Hermine I., and Thomas Lutz. "Subcutaneous Abatacept in Patients with Polyarticular-course Juvenile Idiopathic Arthritis: Results from a Phase III Open-label Study." Arthritis & Rheumatology, vol. 70, no. 7, 2018, https://doi.org/10.1002/art.40466.